Cutting Cost in Medicare: How About Considering Cost First?
This article was originally published in RPM Report
Executive Summary
A modest proposal for the austerity era: let the federal government factor cost into coverage decisions for Medicare Part B. For biopharma companies, that sounds like a terrible idea—but, in the long term, the alternatives just might be much worse.